2020 Speakers

Nicholas Agard, Scientist, Genentech

Nicholas Agard | Scientist | Genentech » speaking at Festival of Biologics US

Andrew Allen, President and Chief Executive Officer, Gritstone Oncology

Sameer Awsare, Associate Executive Director, The Permanente Medical Group Inc

Parastoo Azadi, Technical Director Of Analytical Services And Senior Research Scientist, Complex Carbohydrate Research Center

Parastoo Azadi | Technical Director Of Analytical Services And Senior Research Scientist | Complex Carbohydrate Research Center » speaking at Festival of Biologics US

Greg Babcock, Vice President, Research, Visterra Inc.

Greg Babcock | Vice President, Research | Visterra Inc. » speaking at Festival of Biologics US

Julio Baez, Bioengineering Industrial Advisor, University of California San Diego

Dorthe Bartels, Strategic Adviser, Amgros

Andres Perez Bay, Senior Staff Scientist, Regeneron Pharmaceuticals

Andres Perez Bay | Senior Staff Scientist | Regeneron Pharmaceuticals » speaking at Festival of Biologics US

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Alexey Berezhnoy, Scientist Ii, MacroGenics

Alexey Berezhnoy | Scientist Ii | MacroGenics » speaking at Festival of Biologics US

Ezio Bonvini, Chief Scientific Officer, MacroGenics

Ezio Bonvini | Chief Scientific Officer | MacroGenics » speaking at Festival of Biologics US

Zachary Bornholdt, Director, Antibody Discovery, Mapp Biopharmaceuticals

Zachary Bornholdt | Director, Antibody Discovery | Mapp Biopharmaceuticals » speaking at Festival of Biologics US

Martin Brenner, Chief Scientific Officer, Pfenex Inc

Kate Broderick, Vice President, Research And Development, Inovio Pharmaceuticals

Cory Brooks, Associate Professor, California State University, Fresno

Cory Brooks | Associate Professor | California State University, Fresno » speaking at Festival of Biologics US

Eve Bukowski, Vice President, Patient Advocacy, Education & Outreach, California Life Sciences Association - CLSA

Eve Bukowski | Vice President, Patient Advocacy, Education & Outreach | California Life Sciences Association - CLSA » speaking at Festival of Biologics US

Jim Caggiano, Chief Executive Officer, Dendreon

Jim Caggiano | Chief Executive Officer | Dendreon » speaking at Festival of Biologics US

Saso Cemerski, Senior Director of Translational Immunology, Cue Biopharma

Brian Champion, CSO, Psioxus Therapeutics Ltd

Kartik Chandran, Associate Professor, Department of Microbiology & Immunology, Albert Einstein College of Medicine

Kartik Chandran | Associate Professor, Department of Microbiology & Immunology | Albert Einstein College of Medicine » speaking at Festival of Biologics US

Mark Chiu, Associate Director, Multispecific Biologics Engineering, Janssen Research and Development

Mark Chiu | Associate Director, Multispecific Biologics Engineering | Janssen Research and Development » speaking at Festival of Biologics US

Yongku Cho, Associate Chemical Professor, University of Connecticut

Yongku Cho | Associate Chemical Professor | University of Connecticut » speaking at Festival of Biologics US

Partha Chowdhury, Senior Director And Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury | Senior Director And Head, Antibody Discovery | Sanofi Genzyme » speaking at Festival of Biologics US

Mark Cobbold, Associate Professor, Harvard Medical School

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Dr Ezra Cohen | Associate Director Of Moores Cancer Center | U.C. San Diego Moores Cancer Center » speaking at Festival of Biologics US

Steven Corn, Founder and CEO, Metis Advocacy

Kelly Coulbourne, Allergan

Prentice Curry, Vice President Quality And Operations, Kite Pharma, a Gilead Company

Charles E Daniels, Associate Dean and Chief Pharmacy Officer, UC San Diego Skaggs School Of Pharmacy And Pharmaceutical Sciences

Jennifer Day, Coordinator, Emerging Therapeutics Strategy Program, Kaiser Permanente

Jennifer Day | Coordinator, Emerging Therapeutics Strategy Program | Kaiser Permanente » speaking at Festival of Biologics US

Ross Day, Former Director, Pharmacy Contracting, Vizient Inc

Annick De Vries, Head Diagnostics, Biologics, Sanquin

John Delaney, Executive Director, Amgen Biologics Discovery, Amgen Inc

John Delaney | Executive Director, Amgen Biologics Discovery | Amgen Inc » speaking at Festival of Biologics US

Richard Ding, Director Of Downstream Purification And Manufacturing, AnaptysBio, Inc.

Ramana Doppalapudi, Director Of Chemistry, Avidity BioSciences

Ramana Doppalapudi | Director Of Chemistry | Avidity BioSciences » speaking at Festival of Biologics US

David Dornan, Senior Vice President and Head of Research, Bolt Biotherapeutics

Prof Stefan Duebel, Director, Braunschweig University of Technology

Peter Emtage, Senior Vice President, Global Head Of Cell Therapy Research, Kite Pharma, a Gilead Company

Justin Eyquem, Parker Institute Research Fellow, University of California San Francisco

Mourad Farouk Rezk, Global Head of Medical and Regulatory, Biosimilars, Biogen

Mourad Farouk Rezk | Global Head of Medical and Regulatory, Biosimilars | Biogen » speaking at Festival of Biologics US

David Fontana, Vice President, Strategic Alliances And Collaborations; Program Lead JCAR017, Juno Therapeutics

David Fontana | Vice President, Strategic Alliances And Collaborations; Program Lead JCAR017 | Juno Therapeutics » speaking at Festival of Biologics US

Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Jeffrey Froude | Major, Stm, Vaccines And Therapeutics Division | Defense Threat Reduction Agency » speaking at Festival of Biologics US

Joseph Fuhr, Professor Of Economics, Widener University

Vimal Gandhi, Director, Global Biosimilar Operations And Strategy, AstraZeneca

Vimal Gandhi | Director, Global Biosimilar Operations And Strategy | AstraZeneca » speaking at Festival of Biologics US

Julie Gerberding, Executive Vice President, Communications, Global Policy, and Population Health & Chief Patient Officer, Merck

Julie Gerberding | Executive Vice President, Communications, Global Policy, and Population Health & Chief Patient Officer | Merck » speaking at Festival of Biologics US

Sanjeev Gupta, General Manager (Advanced Biotech), Ipca Laboratories: Pharmaceutical Company

Nassir Habboubi, Chief Medical Officer, Celularity

Eric Halioua, President And Chief Executive Officer, PDC*line pharma SA

Eric Halioua | President And Chief Executive Officer | PDC*line pharma SA » speaking at Festival of Biologics US

Brenda Hann, Director, Clinical Trials Operations, Stanford University School of Medicine

James Heath, President and Professor, Institute For Systems Biology

Nacer Hedroug, Director QA Ops Injectable Vertical & Tech Transfer, Mylan

Nacer Hedroug | Director QA Ops Injectable Vertical & Tech Transfer | Mylan » speaking at Festival of Biologics US

Gerard Hoehn, Senior Medical Director, Oncology & Biosimilars, Teva Pharmaceuticals U.S.A.

Gerard Hoehn | Senior Medical Director, Oncology & Biosimilars | Teva Pharmaceuticals U.S.A. » speaking at Festival of Biologics US

Huiguo (Forrest) Hu, General Manager Of International Business, 3SBio Inc

Dr Laurent Humeau, Senior Vice President, Research And Development, Inovio Pharmaceuticals

Arshad Jamil, Associate Vice President & Head - Intellectual Property Rights, Biocon Limited

Elizabeth Johnson, Biologics Coordinator, Allergy Partners, P.A.

Doug Jolly, Executive Vice President Of Research And Pharmaceutical Development, Tocagen Inc

Doug Jolly | Executive Vice President Of Research And Pharmaceutical Development | Tocagen Inc » speaking at Festival of Biologics US

Steven Jonas, Researcher, UCLA

Steven Jonas | Researcher | UCLA » speaking at Festival of Biologics US

Dan Kaufman, Professor of Medicine, Division of Regenerative Medicine. Director of Cell Therapy, U.C.S.D.

Dan Kaufman | Professor of Medicine, Division of Regenerative Medicine. Director of Cell Therapy | U.C.S.D. » speaking at Festival of Biologics US

Brian Kay, Professor, Department of Biological Sciences, LAS Distinguished Professor & University Scholar, University of Illinois

Marilyn Kehry, Vice President, Cell And Functional Biology, AnaptysBio, Inc.

Marilyn Kehry | Vice President, Cell And Functional Biology | AnaptysBio, Inc. » speaking at Festival of Biologics US

Bruce Keyt, Chief Scientific Officer, IgM. Biosciences Inc

Bruce Keyt | Chief Scientific Officer | IgM. Biosciences Inc » speaking at Festival of Biologics US

Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Vadim Klyushnichenko | Vice President Of Pharmaceutical Development And Quality | Calibr, a division of Scripps Research » speaking at Festival of Biologics US

Andrew Korytko, Lead External Innovation, Biotechnology Discovery Research, Eli Lilly and Company

Giedre Krenciute, Research Associate, St. Jude Children's Research Hospital

Mohamed Ladha, Vice President and Head, Commercial, Tocagen Inc

Mohamed Ladha | Vice President and Head, Commercial | Tocagen Inc » speaking at Festival of Biologics US

Dr James Legg, Vice President, Research And Development, Crescendo Biologics Ltd

Steve Lehrer, Managing Director, SBLehrer LLC

Bruce Leicher, Attorney And Former Senior Vice President And General Counsel, Momenta Pharmaceuticals Inc

Blake Leitch, Global Head Of Marketing, Biosimilars, Biogen

Blake Leitch | Global Head Of Marketing, Biosimilars | Biogen » speaking at Festival of Biologics US

Adam Levysohn, Executive Director, Global Market Access, Biosimilars, Biogen

Nathan Lewis, Associate Professor, Department Of Pediatrics And Bioengineering,, University of California San Diego

Nathan Lewis | Associate Professor, Department Of Pediatrics And Bioengineering, | University of California San Diego » speaking at Festival of Biologics US

Bernd Liedert, Senior Director, Clinical Development Biosimilars, Boehringer Ingelheim Pharma Co Gmbh

Bernd Liedert | Senior Director, Clinical Development Biosimilars | Boehringer Ingelheim Pharma Co Gmbh » speaking at Festival of Biologics US

Cate Lockhart, Executive Director, Biologics and Biosimilars Collective Intelligence Consortium

Lawrence Lum, Professor Of Oncology, University of Virginia School of Medicine

Maria-Céu Machado, President of the Executive Board, Infarmed

Loui Madakamutil, Senior Vice President, Head Of Discovery And Preclinical Development, Nektar Therapeutics

Loui Madakamutil | Senior Vice President, Head Of Discovery And Preclinical Development | Nektar Therapeutics » speaking at Festival of Biologics US

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Jay Mandrekar, Professor Of Biostatistics And Neurology, Mayo Clinic

Peter Marks, Director, Center For Biologics Evaluation And Research (Cber), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (Cber) | U.S. Food and Drug Administration » speaking at Festival of Biologics US

Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Werner Meier, Chief Scientific Officer, Revitope Oncology, Inc.

Werner Meier | Chief Scientific Officer | Revitope Oncology, Inc. » speaking at Festival of Biologics US

Jeffrey Miller, Professor of Medicine, Hematology, Oncology and Transplantation, Deputy Director, Masonic Cancer Center, University of Minnesota

Liviu Movileanu, Syracuse University

Liviu Movileanu |  | Syracuse University » speaking at Festival of Biologics US

Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi

Marc Nasoff, Biologics, Chief Scientific Officer, Fortis Therapeutics

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Elisabeth Nyakatura, Research Assistant Professor, Albert Einstein College of Medicine

Elisabeth Nyakatura | Research Assistant Professor | Albert Einstein College of Medicine » speaking at Festival of Biologics US

Sari Pesonen, Vice President Scientific And Clinical Development, Co-Founder, Valo Therapeutics

Nicolas Poirier, Chief Scientific Officer, O.S.E. Immunotherapeutics

Nicolas Poirier | Chief Scientific Officer | O.S.E. Immunotherapeutics » speaking at Festival of Biologics US

Christophe Queva, Chief Scientific Officer, Oncorus

Christophe Queva | Chief Scientific Officer | Oncorus » speaking at Festival of Biologics US

Sundar Ramanan, Vice President Of Regulatory Affairs, Biocon Limited

Sundar Ramanan | Vice President Of Regulatory Affairs | Biocon Limited » speaking at Festival of Biologics US

Nate Root, Associate Director, Clinical Disclosure And Transparency, Ionis Pharmaceuticals

Brandon Ruotolo, Professor of Chemistry, University of Michigan

Shahram Salek-Ardakani, Senior Cancer Immunology Director, Pfizer

Shahram Salek-Ardakani | Senior Cancer Immunology Director | Pfizer » speaking at Festival of Biologics US

Keri Schadler, MD Anderson Cancer Center

Keri Schadler |  | MD Anderson Cancer Center » speaking at Festival of Biologics US

Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Stephen Schoenberger | Professor | La Jolla Institute for Allergy and Immunology » speaking at Festival of Biologics US

Mike Schopperle, Chief Executive Officer, CureMeta Llc

Mike Schopperle | Chief Executive Officer | CureMeta Llc » speaking at Festival of Biologics US

Enrique Seoane-Vazquez, Professor of Pharmaceutical Economics, Regulation and Policy, Chapman University

Enrique Seoane-Vazquez | Professor of Pharmaceutical Economics, Regulation and Policy | Chapman University » speaking at Festival of Biologics US

Joan Shen, I-Mab Biopharma

Joan Shen |  | I-Mab Biopharma » speaking at Festival of Biologics US

Christine M Simmon, Executive Director, Biosimilars Council

Christine M Simmon | Executive Director | Biosimilars Council » speaking at Festival of Biologics US

Vaughn Smider, Professor, The Applied Biomedical Science Institute

Vaughn Smider | Professor | The Applied Biomedical Science Institute » speaking at Festival of Biologics US

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

David Sourdive, Executive Vice President Technical Operations, Cellectis SA

Philipp Spycher, Psi Founder Fellow, Paul Scherrer Institut

Philipp Spycher | Psi Founder Fellow | Paul Scherrer Institut » speaking at Festival of Biologics US

Ryan Stafford, Director, Protein Engineering - Discovery, Sutro Biopharma

Ryan Stafford | Director, Protein Engineering - Discovery | Sutro Biopharma » speaking at Festival of Biologics US

Gary Starling, Associate Vice President, Discovery Biologics, Merck

Gary Starling | Associate Vice President, Discovery Biologics | Merck » speaking at Festival of Biologics US

Denise Steckel, Head, Clinical Collaborations Management, Genentech

Hiroaki Suga, Professor Of Bioorganic Chemistry, The University of Tokyo

Chad Swanson, Senior Neuroscience Clinical Research Director, Eisai

Chad Swanson | Senior Neuroscience Clinical Research Director | Eisai » speaking at Festival of Biologics US

Christopher Thanos, CEO, Co-Founder, Actym Therapeutics

Christopher Thanos | CEO, Co-Founder | Actym Therapeutics » speaking at Festival of Biologics US

Ms Bracha Timan, Head of Bioassays and Technologies of Israel, Teva

Ms Bracha Timan | Head of Bioassays and Technologies of Israel | Teva » speaking at Festival of Biologics US

Dr Frédéric Triebel, Chief Scientific Officer And Medical Officer, Immutep Ltd

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Vu Truong | Chief Executive Officer And Chief Scientific Officer | Aridis Pharmaceuticals » speaking at Festival of Biologics US

Dr Bob Valamehr, Vice President Of Cancer Immunotherapy, Fate Therapeutics

Dr Bob Valamehr | Vice President Of Cancer Immunotherapy | Fate Therapeutics » speaking at Festival of Biologics US

Antonella Vitiello, Founder and Chief Executive Officer, PersImmune

Antonella Vitiello | Founder and Chief Executive Officer | PersImmune » speaking at Festival of Biologics US

Frank Walsh, Chief Executive Officer, Ossianix, Inc.

Feng Wang, Professor And Principal Investigator, Chinese Academy of Science

Anna Rose Welch, Executive Editor, Biosimilar Development

Robert Wild, Chief Scientific Officer, Dracen Pharmaceuticals

Michael Hongwei Xie, Executive Director of Bioassay and Analytical Development, Shanghai Henlius Biotech

Oladapo Yeku, Medical Oncology Fellow, Memorial Sloan-Kettering Cancer Center

Michael Yellin, Vice President Of Clinical Science, Celldex Therapeutics

Christina Yi, Chief Operations Officer, Dendreon

Christina Yi | Chief Operations Officer | Dendreon » speaking at Festival of Biologics US
"}" style="font-size: 10pt; font-family: Arial;">

Nicholas Agard, Scientist, Genentech

Nicholas Agard | Scientist | Genentech » speaking at Festival of Biologics US

Andrew Allen, President and Chief Executive Officer, Gritstone Oncology

Sameer Awsare, Associate Executive Director, The Permanente Medical Group Inc

Parastoo Azadi, Technical Director Of Analytical Services And Senior Research Scientist, Complex Carbohydrate Research Center

Parastoo Azadi | Technical Director Of Analytical Services And Senior Research Scientist | Complex Carbohydrate Research Center » speaking at Festival of Biologics US

Greg Babcock, Vice President, Research, Visterra Inc.

Greg Babcock | Vice President, Research | Visterra Inc. » speaking at Festival of Biologics US

Julio Baez, Bioengineering Industrial Advisor, University of California San Diego

Dorthe Bartels, Strategic Adviser, Amgros

Andres Perez Bay, Senior Staff Scientist, Regeneron Pharmaceuticals

Andres Perez Bay | Senior Staff Scientist | Regeneron Pharmaceuticals » speaking at Festival of Biologics US

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Alexey Berezhnoy, Scientist Ii, MacroGenics

Alexey Berezhnoy | Scientist Ii | MacroGenics » speaking at Festival of Biologics US

Ezio Bonvini, Chief Scientific Officer, MacroGenics

Ezio Bonvini | Chief Scientific Officer | MacroGenics » speaking at Festival of Biologics US

Zachary Bornholdt, Director, Antibody Discovery, Mapp Biopharmaceuticals

Zachary Bornholdt | Director, Antibody Discovery | Mapp Biopharmaceuticals » speaking at Festival of Biologics US

Martin Brenner, Chief Scientific Officer, Pfenex Inc

Kate Broderick, Vice President, Research And Development, Inovio Pharmaceuticals

Cory Brooks, Associate Professor, California State University, Fresno

Cory Brooks | Associate Professor | California State University, Fresno » speaking at Festival of Biologics US

Eve Bukowski, Vice President, Patient Advocacy, Education & Outreach, California Life Sciences Association - CLSA

Eve Bukowski | Vice President, Patient Advocacy, Education & Outreach | California Life Sciences Association - CLSA » speaking at Festival of Biologics US

Jim Caggiano, Chief Executive Officer, Dendreon

Jim Caggiano | Chief Executive Officer | Dendreon » speaking at Festival of Biologics US

Saso Cemerski, Senior Director of Translational Immunology, Cue Biopharma

Brian Champion, CSO, Psioxus Therapeutics Ltd

Kartik Chandran, Associate Professor, Department of Microbiology & Immunology, Albert Einstein College of Medicine

Kartik Chandran | Associate Professor, Department of Microbiology & Immunology | Albert Einstein College of Medicine » speaking at Festival of Biologics US

Mark Chiu, Associate Director, Multispecific Biologics Engineering, Janssen Research and Development

Mark Chiu | Associate Director, Multispecific Biologics Engineering | Janssen Research and Development » speaking at Festival of Biologics US

Yongku Cho, Associate Chemical Professor, University of Connecticut

Yongku Cho | Associate Chemical Professor | University of Connecticut » speaking at Festival of Biologics US

Partha Chowdhury, Senior Director And Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury | Senior Director And Head, Antibody Discovery | Sanofi Genzyme » speaking at Festival of Biologics US

Mark Cobbold, Associate Professor, Harvard Medical School

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Dr Ezra Cohen | Associate Director Of Moores Cancer Center | U.C. San Diego Moores Cancer Center » speaking at Festival of Biologics US

Steven Corn, Founder and CEO, Metis Advocacy

Kelly Coulbourne, Allergan

Prentice Curry, Vice President Quality And Operations, Kite Pharma, a Gilead Company

Charles E Daniels, Associate Dean and Chief Pharmacy Officer, UC San Diego Skaggs School Of Pharmacy And Pharmaceutical Sciences

Jennifer Day, Coordinator, Emerging Therapeutics Strategy Program, Kaiser Permanente

Jennifer Day | Coordinator, Emerging Therapeutics Strategy Program | Kaiser Permanente » speaking at Festival of Biologics US

Ross Day, Former Director, Pharmacy Contracting, Vizient Inc

Annick De Vries, Head Diagnostics, Biologics, Sanquin

John Delaney, Executive Director, Amgen Biologics Discovery, Amgen Inc

John Delaney | Executive Director, Amgen Biologics Discovery | Amgen Inc » speaking at Festival of Biologics US

Richard Ding, Director Of Downstream Purification And Manufacturing, AnaptysBio, Inc.

Ramana Doppalapudi, Director Of Chemistry, Avidity BioSciences

Ramana Doppalapudi | Director Of Chemistry | Avidity BioSciences » speaking at Festival of Biologics US

David Dornan, Senior Vice President and Head of Research, Bolt Biotherapeutics

Prof Stefan Duebel, Director, Braunschweig University of Technology

Peter Emtage, Senior Vice President, Global Head Of Cell Therapy Research, Kite Pharma, a Gilead Company

Justin Eyquem, Parker Institute Research Fellow, University of California San Francisco

Mourad Farouk Rezk, Global Head of Medical and Regulatory, Biosimilars, Biogen

Mourad Farouk Rezk | Global Head of Medical and Regulatory, Biosimilars | Biogen » speaking at Festival of Biologics US

David Fontana, Vice President, Strategic Alliances And Collaborations; Program Lead JCAR017, Juno Therapeutics

David Fontana | Vice President, Strategic Alliances And Collaborations; Program Lead JCAR017 | Juno Therapeutics » speaking at Festival of Biologics US

Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Jeffrey Froude | Major, Stm, Vaccines And Therapeutics Division | Defense Threat Reduction Agency » speaking at Festival of Biologics US

Joseph Fuhr, Professor Of Economics, Widener University

Vimal Gandhi, Director, Global Biosimilar Operations And Strategy, AstraZeneca

Vimal Gandhi | Director, Global Biosimilar Operations And Strategy | AstraZeneca » speaking at Festival of Biologics US

Julie Gerberding, Executive Vice President, Communications, Global Policy, and Population Health & Chief Patient Officer, Merck

Julie Gerberding | Executive Vice President, Communications, Global Policy, and Population Health & Chief Patient Officer | Merck » speaking at Festival of Biologics US

Sanjeev Gupta, General Manager (Advanced Biotech), Ipca Laboratories: Pharmaceutical Company

Nassir Habboubi, Chief Medical Officer, Celularity

Eric Halioua, President And Chief Executive Officer, PDC*line pharma SA

Eric Halioua | President And Chief Executive Officer | PDC*line pharma SA » speaking at Festival of Biologics US

Brenda Hann, Director, Clinical Trials Operations, Stanford University School of Medicine

James Heath, President and Professor, Institute For Systems Biology

Nacer Hedroug, Director QA Ops Injectable Vertical & Tech Transfer, Mylan

Nacer Hedroug | Director QA Ops Injectable Vertical & Tech Transfer | Mylan » speaking at Festival of Biologics US

Gerard Hoehn, Senior Medical Director, Oncology & Biosimilars, Teva Pharmaceuticals U.S.A.

Gerard Hoehn | Senior Medical Director, Oncology & Biosimilars | Teva Pharmaceuticals U.S.A. » speaking at Festival of Biologics US

Huiguo (Forrest) Hu, General Manager Of International Business, 3SBio Inc

Dr Laurent Humeau, Senior Vice President, Research And Development, Inovio Pharmaceuticals

Arshad Jamil, Associate Vice President & Head - Intellectual Property Rights, Biocon Limited

Elizabeth Johnson, Biologics Coordinator, Allergy Partners, P.A.

Doug Jolly, Executive Vice President Of Research And Pharmaceutical Development, Tocagen Inc

Doug Jolly | Executive Vice President Of Research And Pharmaceutical Development | Tocagen Inc » speaking at Festival of Biologics US

Steven Jonas, Researcher, UCLA

Steven Jonas | Researcher | UCLA » speaking at Festival of Biologics US

Dan Kaufman, Professor of Medicine, Division of Regenerative Medicine. Director of Cell Therapy, U.C.S.D.

Dan Kaufman | Professor of Medicine, Division of Regenerative Medicine. Director of Cell Therapy | U.C.S.D. » speaking at Festival of Biologics US

Brian Kay, Professor, Department of Biological Sciences, LAS Distinguished Professor & University Scholar, University of Illinois

Marilyn Kehry, Vice President, Cell And Functional Biology, AnaptysBio, Inc.

Marilyn Kehry | Vice President, Cell And Functional Biology | AnaptysBio, Inc. » speaking at Festival of Biologics US

Bruce Keyt, Chief Scientific Officer, IgM. Biosciences Inc

Bruce Keyt | Chief Scientific Officer | IgM. Biosciences Inc » speaking at Festival of Biologics US

Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Vadim Klyushnichenko | Vice President Of Pharmaceutical Development And Quality | Calibr, a division of Scripps Research » speaking at Festival of Biologics US

Andrew Korytko, Lead External Innovation, Biotechnology Discovery Research, Eli Lilly and Company

Giedre Krenciute, Research Associate, St. Jude Children's Research Hospital

Mohamed Ladha, Vice President and Head, Commercial, Tocagen Inc

Mohamed Ladha | Vice President and Head, Commercial | Tocagen Inc » speaking at Festival of Biologics US

Dr James Legg, Vice President, Research And Development, Crescendo Biologics Ltd

Steve Lehrer, Managing Director, SBLehrer LLC

Bruce Leicher, Attorney And Former Senior Vice President And General Counsel, Momenta Pharmaceuticals Inc

Blake Leitch, Global Head Of Marketing, Biosimilars, Biogen

Blake Leitch | Global Head Of Marketing, Biosimilars | Biogen » speaking at Festival of Biologics US

Adam Levysohn, Executive Director, Global Market Access, Biosimilars, Biogen

Nathan Lewis, Associate Professor, Department Of Pediatrics And Bioengineering,, University of California San Diego

Nathan Lewis | Associate Professor, Department Of Pediatrics And Bioengineering, | University of California San Diego » speaking at Festival of Biologics US

Bernd Liedert, Senior Director, Clinical Development Biosimilars, Boehringer Ingelheim Pharma Co Gmbh

Bernd Liedert | Senior Director, Clinical Development Biosimilars | Boehringer Ingelheim Pharma Co Gmbh » speaking at Festival of Biologics US

Cate Lockhart, Executive Director, Biologics and Biosimilars Collective Intelligence Consortium

Lawrence Lum, Professor Of Oncology, University of Virginia School of Medicine

Maria-Céu Machado, President of the Executive Board, Infarmed

Loui Madakamutil, Senior Vice President, Head Of Discovery And Preclinical Development, Nektar Therapeutics

Loui Madakamutil | Senior Vice President, Head Of Discovery And Preclinical Development | Nektar Therapeutics » speaking at Festival of Biologics US

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Jay Mandrekar, Professor Of Biostatistics And Neurology, Mayo Clinic

Peter Marks, Director, Center For Biologics Evaluation And Research (Cber), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (Cber) | U.S. Food and Drug Administration » speaking at Festival of Biologics US

Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Werner Meier, Chief Scientific Officer, Revitope Oncology, Inc.

Werner Meier | Chief Scientific Officer | Revitope Oncology, Inc. » speaking at Festival of Biologics US

Jeffrey Miller, Professor of Medicine, Hematology, Oncology and Transplantation, Deputy Director, Masonic Cancer Center, University of Minnesota

Liviu Movileanu, Syracuse University

Liviu Movileanu |  | Syracuse University » speaking at Festival of Biologics US

Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi

Marc Nasoff, Biologics, Chief Scientific Officer, Fortis Therapeutics

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Elisabeth Nyakatura, Research Assistant Professor, Albert Einstein College of Medicine

Elisabeth Nyakatura | Research Assistant Professor | Albert Einstein College of Medicine » speaking at Festival of Biologics US

Sari Pesonen, Vice President Scientific And Clinical Development, Co-Founder, Valo Therapeutics

Nicolas Poirier, Chief Scientific Officer, O.S.E. Immunotherapeutics

Nicolas Poirier | Chief Scientific Officer | O.S.E. Immunotherapeutics » speaking at Festival of Biologics US

Christophe Queva, Chief Scientific Officer, Oncorus

Christophe Queva | Chief Scientific Officer | Oncorus » speaking at Festival of Biologics US

Sundar Ramanan, Vice President Of Regulatory Affairs, Biocon Limited

Sundar Ramanan | Vice President Of Regulatory Affairs | Biocon Limited » speaking at Festival of Biologics US

Nate Root, Associate Director, Clinical Disclosure And Transparency, Ionis Pharmaceuticals

Brandon Ruotolo, Professor of Chemistry, University of Michigan

Shahram Salek-Ardakani, Senior Cancer Immunology Director, Pfizer

Shahram Salek-Ardakani | Senior Cancer Immunology Director | Pfizer » speaking at Festival of Biologics US

Keri Schadler, MD Anderson Cancer Center

Keri Schadler |  | MD Anderson Cancer Center » speaking at Festival of Biologics US

Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Stephen Schoenberger | Professor | La Jolla Institute for Allergy and Immunology » speaking at Festival of Biologics US

Mike Schopperle, Chief Executive Officer, CureMeta Llc

Mike Schopperle | Chief Executive Officer | CureMeta Llc » speaking at Festival of Biologics US

Enrique Seoane-Vazquez, Professor of Pharmaceutical Economics, Regulation and Policy, Chapman University

Enrique Seoane-Vazquez | Professor of Pharmaceutical Economics, Regulation and Policy | Chapman University » speaking at Festival of Biologics US

Joan Shen, I-Mab Biopharma

Joan Shen |  | I-Mab Biopharma » speaking at Festival of Biologics US

Christine M Simmon, Executive Director, Biosimilars Council

Christine M Simmon | Executive Director | Biosimilars Council » speaking at Festival of Biologics US

Vaughn Smider, Professor, The Applied Biomedical Science Institute

Vaughn Smider | Professor | The Applied Biomedical Science Institute » speaking at Festival of Biologics US

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

David Sourdive, Executive Vice President Technical Operations, Cellectis SA

Philipp Spycher, Psi Founder Fellow, Paul Scherrer Institut

Philipp Spycher | Psi Founder Fellow | Paul Scherrer Institut » speaking at Festival of Biologics US

Ryan Stafford, Director, Protein Engineering - Discovery, Sutro Biopharma

Ryan Stafford | Director, Protein Engineering - Discovery | Sutro Biopharma » speaking at Festival of Biologics US

Gary Starling, Associate Vice President, Discovery Biologics, Merck

Gary Starling | Associate Vice President, Discovery Biologics | Merck » speaking at Festival of Biologics US

Denise Steckel, Head, Clinical Collaborations Management, Genentech

Hiroaki Suga, Professor Of Bioorganic Chemistry, The University of Tokyo

Chad Swanson, Senior Neuroscience Clinical Research Director, Eisai

Chad Swanson | Senior Neuroscience Clinical Research Director | Eisai » speaking at Festival of Biologics US

Christopher Thanos, CEO, Co-Founder, Actym Therapeutics

Christopher Thanos | CEO, Co-Founder | Actym Therapeutics » speaking at Festival of Biologics US

Ms Bracha Timan, Head of Bioassays and Technologies of Israel, Teva

Ms Bracha Timan | Head of Bioassays and Technologies of Israel | Teva » speaking at Festival of Biologics US

Dr Frédéric Triebel, Chief Scientific Officer And Medical Officer, Immutep Ltd

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Vu Truong | Chief Executive Officer And Chief Scientific Officer | Aridis Pharmaceuticals » speaking at Festival of Biologics US

Dr Bob Valamehr, Vice President Of Cancer Immunotherapy, Fate Therapeutics

Dr Bob Valamehr | Vice President Of Cancer Immunotherapy | Fate Therapeutics » speaking at Festival of Biologics US

Antonella Vitiello, Founder and Chief Executive Officer, PersImmune

Antonella Vitiello | Founder and Chief Executive Officer | PersImmune » speaking at Festival of Biologics US

Frank Walsh, Chief Executive Officer, Ossianix, Inc.

Feng Wang, Professor And Principal Investigator, Chinese Academy of Science

Anna Rose Welch, Executive Editor, Biosimilar Development

Robert Wild, Chief Scientific Officer, Dracen Pharmaceuticals

Michael Hongwei Xie, Executive Director of Bioassay and Analytical Development, Shanghai Henlius Biotech

Oladapo Yeku, Medical Oncology Fellow, Memorial Sloan-Kettering Cancer Center

Michael Yellin, Vice President Of Clinical Science, Celldex Therapeutics

Christina Yi, Chief Operations Officer, Dendreon

Christina Yi | Chief Operations Officer | Dendreon » speaking at Festival of Biologics US
 


 

GET INVOLVED AT THE  FESTIVAL OF BIOLOGICS USA

 

To Sponsor Or Exhibit

 

Derek Cavanagh
derek.cavanagh@terrapinn.com
t/ +44 (0)207 092 1297

 

 

 

To Speak

 

Joan Shutt
joan.shutt@terrapinn.com
t/ +44 (0)207 092 1134

 

 

 

To Register

 

Tayyab Abbasi
Tayyab.Abbasi@terrapinn.com
t/ +44 (0)207 092 1210